Syd Financial Inc. (the "Company" or "Syd") announced that further to its press release dated June 25, 2019 the Company has entered into a definitive business combination agreement dated effective September 6, 2019 (the "Agreement") with Santa Marta Life Sciences Corp. ("Santa Marta") and a wholly-owned subsidiary of the Company, 1221439 B.C. Ltd. ("Newco"), formed for the purpose of completing the transaction. Santa Marta is an arm's length company incorporated under the Business Corporations Act (British Columbia) (the "BCBCA"). Upon completion of the Transaction, and subject to the approval of the CSE, the current directors and officers of the Company will resign, with the exception of Mario Pezzente who will remain as a director of the Resulting Issuer. Nick Standish will be appointed as President, Chief Executive Officer and as a director of the Resulting Issuer. Blair Lowther and Derek Boyd will also be appointed as directors of the Resulting Issuer. A nominee of Santa Marta shall be appointed as Chief Financial Officer of the Resulting Issuer. One additional nominee of Santa Marta will be proposed as an additional director of the Resulting Issuer for election by the shareholders after the completion of the Transaction at the first annual general meeting of shareholders of the Resulting Issuer.